Quantcast
Last updated on April 23, 2014 at 16:13 EDT

Latest Hepatitis D Stories

2014-04-11 12:58:41

Mortality from viral hepatitis is significantly higher than from HIV/AIDS across EU countries, according to results from The Global Burden of Disease Study 2010 (GBD 2010) which was announced for the first time today at the International Liver CongressTM 2014. GBD 2010 is the most recent version of a large epidemiological study funded by the Bill and Melinda Gates Foundation and coordinated by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. In the...

2014-04-02 08:33:17

MOSCOW, April 2, 2014 /PRNewswire/ -- Hepatera Ltd. [http://www.hepatera.ru/?ln=en ] announces initiation of a clinical trial investigating Myrcludex B in chronically HBV infected patients who are also infected with hepatitis delta virus (HDV). Hepatera is financed by Maxwell Biotech Venture Fund [http://www.maxwellbiotech.com ] formed with the participation of RVC [http://www.rusventure.ru/en ] - Russia's government fund of venture capital funds. Hepatera was...

2013-10-08 08:29:11

TITUSVILLE, N.J., Oct. 8, 2013 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. (Janssen) announced today the acquisition of the investigational compound GSK2336805, an NS5a replication complex inhibitor in Phase 2 development for the treatment of chronic hepatitis C, from an affiliate of GlaxoSmithKline plc. Janssen has acquired all rights to develop and commercialize GSK2336805, including in combination with other drugs. Financial details of the agreement have not been disclosed. Janssen...

2013-07-28 04:20:12

BRUSSELS, July 28, 2013 /PRNewswire/ -- There are still startling differences in hepatitis prevention and access to treatment across the different EU Member States. Almost one year after the publication of the Euro Hepatitis Care Index by the European Liver Patients Association (ELPA), the situation has not improved much. "Even the EU Member States ranking high on the Index do not perform consistently well, but rather on specific aspects and are lagging behind on others",...

2013-07-26 16:23:13

Volunteer Team Urges City Residents and Visitors to Come Out, Be Counted, and Paint at Hepatitis Awareness Event, Chinatown Park, 10:00 a.m. on July 28th. BOSTON, July 26, 2013 /PRNewswire/ -- Students at Harvard, Massachusetts Institute of Technology and Brown University, Massachusetts Asian & Pacific Islanders (MAP) for Health and local employee volunteers of Quest Diagnostics will join elected officials, community and healthcare leaders and Boston residents to once again rally...

2013-06-06 11:30:11

Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus (HBV) replication. Findings published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, suggest seasonal fluctuations in vitamin D and HBV levels point to a link in these variables among patients with chronic HBV. While highly effective vaccines are available, HBV still remains one of the most significant infectious diseases...

2013-01-24 23:00:10

The Association of Asian Pacific Community Health Organizations (AAPCHO) received a 3-year grant totaling over $700,000 from the National Institutes of Health (NIH) to develop new Health Information Technology strategies that increase screening for chronic hepatitis B and reduce the impact of hepatitis B among high-risk Asian American and Pacific Islander populations. First study to evaluate health information technology strategies for low-income Asian American and Pacific Islander...

2012-07-27 14:20:35

BOSTON, July 27, 2012 /PRNewswire/ -- Students at Harvard and Massachusetts Institute of Technology aren't the type to take the summer off. Those who comprise a group called Team HBV, while working well-earned and prized internships, are also dedicating their off hours to leading conference calls, sending emails and public service announcements, and distributing flyers in Chinatown and beyond -- all in an attempt to rally elected officials, community and healthcare leaders, and the general...

2012-06-01 11:31:58

Foreign-born persons contribute more than 1 million additional HBV cases The prevalence of chronic hepatitis B virus (HBV) infection in the U.S. may be as high as 2.2 million cases according to a new study now available in Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases. Findings suggest the higher prevalence of chronic HBV can be attributed to foreign-born persons who were infected in their country of origin prior to...

2011-04-03 21:56:55

First new hepatitis B and D treatment for many years Promising new viral hepatitis data presented today at the International Liver CongressTM show that entry inhibitors --a new mechanism of action for drugs to treat viral hepatitis -- could provide the first new hepatitis B and hepatitis D treatments for many years. Most current approved therapies directly target viral replication (e.g. nucleotide/side analogues), and can lead to the development of viral resistance or viral rebound after the...